NextMeds review
NextMeds is a cash-pay telehealth platform offering compounded semaglutide and compounded tirzepatide on a flat monthly membership — one price bundling the medication (if prescribed), telehealth visits.
- Semaglutide
- From $129/mo (plus a separate fee, compounded)
- Tirzepatide
- From $179/mo (plus a separate fee, compounded)
- Coverage
- All 50 states
- Brand-name
- Compounded only
Prices read from NextMeds's own site on . Providers change pricing without notice — check the current figure before you buy.
The scorecard
NextMeds scored on our six Brief Score factors. See the methodology.
What we like
- Flat monthly membership bundles the medication, telehealth visits, a 1:1 care coach and a licensed registered dietitian — one price, no hidden fees
- Same price every dose, no auto-renewal, cancel anytime; free shipping and no insurance needed (FSA eligible)
- Names a compounding pharmacy partner (Foothills Pharmacy) and states it services all 50 states
- Free, no-obligation online assessment before you pay anything
The caveats
- Shows a LegitScript 'approval' but links only a generic directory search, not a verifiable seal — we couldn't independently confirm it
- Promo-driven pricing with a countdown timer and 'price increases' urgency; the standing membership is $129 (sema) / $179 (tirz)
- A technology platform that coordinates care, not the medical provider; individual clinicians and a medical director aren't named on the site
- Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
- Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
The brief
Best for: Readers who want flat-price compounded semaglutide or tirzepatide bundled with a care coach and registered dietitian. NextMeds is a cash-pay telehealth platform offering compounded semaglutide and compounded tirzepatide on a flat monthly membership — one price bundling the medication (if prescribed), telehealth visits.
Ranked #265 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.
Before you decide
The questions readers ask next after reading about NextMeds.
Closest here
The providers scoring nearest NextMeds — the realistic shortlist if you're weighing it.
Weighing NextMeds against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs NextMeds, and every provider that outranks it is listed on the NextMeds alternatives ranking.
- #262Livv— Telehealth weight loss provider offering compounded tirzepatide programs.65/100
- #263Measured— Metabolic-health membership pairing GLP-1 treatment with 1:1 nutrition support and board-certified provider care.65/100
- #264NexLife— NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).65/100
- #266Nucore Health— Nucore Health is a physician-owned, LegitScript-certified telehealth platform serving all 50 states, focused on GLP-1 and longevity care: compounded semaglutide and tirzepatide.65/100
- #267Options Medical Weight Loss— Options Medical Weight Loss offers telehealth medical weight-loss programs built around compounded GLP-1 — semaglutide starting around $239/month and tirzepatide from $299/month.65/100
- #268Rejuve Meds— Rejuve Meds (Rejuve, Inc.) is a GLP-1 weight-loss telehealth service offering doctor-guided compounded semaglutide at $165/mo and dual-action compounded tirzepatide (GLP-1/GIP) at $265/mo.65/100
More providers we track (24)
- #1 CoreAge Rx94
- #2 Eden91
- #3 Trimi89
- #4 Sesame Care87
- #5 ShedRx87
- #6 Sprout Health86
- #7 HealthRX86
- #8 MadeMed86
- #9 Invigor Medical88
- #10 Telos Rx85
- #11 Enhance MD85
- #12 REMEVi87
- #13 Ro87
- #14 Ondra Health87
- #15 Vaylen87
- #16 Vytora Health87
- #17 No BS RX87
- #18 yourEra84
- #19 Strut Health84
- #20 Effecty86
- #21 NiceRx86
- #22 Curex86
- #23 Amazon One Medical86
- #24 AgelessRx85
515 more are filed too — see every provider we track, ranked.
Pricing, states and verification reflect NextMeds's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on NextMeds's site. Not medical advice; see our disclosure.